MoonLake Immunotherapeutics (MLTX) Insider Trading

Over the last 3 months, MLTX insiders made 0 open-market buys and 10 sales, a net sale of -$6.9M (SEC Form 4). Over the last 6 months, 114 institutions increased and 70 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
10
Net (3m)
-$6.9M
Insider trades by month Buys Sells
Jul
Oct
Dec
Apr
May
Jun
Context3-month price +4.5%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Jun 23, 2026Bodenstedt Matthiasofficer: Chief Financial OfficerSell39,120$22.04
Jun 22, 2026BVF PARTNERS L P/ILdirector, 10 percent owner: Grant22,195$19.19
Jun 18, 2026Xavier RamnikdirectorGrant22,195$19.19
Jun 18, 2026Bodenstedt Matthiasofficer: Chief Financial OfficerSell15,082$19.68
Jun 18, 2026Bodenstedt Matthiasofficer: Chief Financial OfficerSell2,794$19.60
Jun 18, 2026Phillips Andrew JohndirectorGrant22,195$19.19
Jun 18, 2026Loy SpikedirectorGrant22,195$19.19
Jun 18, 2026Moukheibir CatherinedirectorGrant22,195$19.19
Jun 17, 2026Reich Kristianofficer: Chief Scientific OfficerSell50,000$18.89
May 13, 2026Bodenstedt Matthiasofficer: Chief Financial OfficerSell13,653$20.02
Apr 16, 2026Bodenstedt Matthiasofficer: Chief Financial OfficerSell2,426$19.56
Apr 14, 2026Santos da Silva Jorgedirector, officer: Chief Executive OfficerSell98,127$18.41
Apr 14, 2026Santos da Silva Jorgedirector, officer: Chief Executive OfficerSell51,873$18.23
Apr 10, 2026Bodenstedt Matthiasofficer: Chief Financial OfficerSell1,925$19.51
Apr 10, 2026Bodenstedt Matthiasofficer: Chief Financial OfficerSell85,870$18.94
Apr 2, 2026BVF PARTNERS L P/ILdirector, 10 percent owner: Sell1,932,354$16.79
Apr 2, 2026BVF PARTNERS L P/ILdirector, 10 percent owner: Sell1,569,116$16.79
Apr 2, 2026BVF PARTNERS L P/ILdirector, 10 percent owner: Sell248,530$16.79
Jan 9, 2026Reich Kristianofficer: Chief Scientific OfficerGrant520,342$11.29
Jan 9, 2026Bodenstedt Matthiasofficer: Chief Financial OfficerGrant354,296
Jan 9, 2026Santos da Silva Jorgedirector, officer: Chief Executive OfficerGrant520,342$11.29
Dec 10, 2025Santos da Silva Jorgedirector, officer: Chief Executive OfficerSell70,000$14.49
Dec 10, 2025Santos da Silva Jorgedirector, officer: Chief Executive OfficerSell130,000$15.08
Dec 10, 2025Reich Kristianofficer: Chief Scientific OfficerSell130,000$15.08
Dec 10, 2025Reich Kristianofficer: Chief Scientific OfficerSell72,908$14.43
Oct 9, 2025Bodenstedt Matthiasofficer: Chief Financial OfficerBuy10,870$9.09
Oct 1, 2025Chen Bihuaother: Former 10% OwnerSell2,800,000$6.61
Oct 1, 2025Chen Bihuaother: Former 10% OwnerSell3,390,943$7.58
Oct 1, 2025Chen Bihuaother: Former 10% OwnerSell70,748$9.38
Oct 1, 2025Chen Bihuaother: Former 10% OwnerSell5,827$6.96

Source: MLTX SEC Form 4 filings, latest Jun 23, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their MLTX positions over the last 6 months (SEC Form 13F).

Increased
114
New positions
82
Reduced
70
Sold out
76
Largest moves
InstitutionActionSharesFiled
BVF INC/ILUnchanged19.8MFeb 17, 2026
BVF INC/ILReduced16.0MMay 15, 2026
JANUS HENDERSON GROUP PLCIncreased6.9MMay 18, 2026
DEEP TRACK CAPITAL, LPIncreased6.4MMay 15, 2026
DEEP TRACK CAPITAL, LPNew Position4.6MFeb 13, 2026
CORMORANT ASSET MANAGEMENT, LPIncreased4.5MMay 15, 2026
CORMORANT ASSET MANAGEMENT, LPIncreased4.4MFeb 17, 2026
D. E. SHAW & CO., INC.New Position2.5MFeb 17, 2026
D. E. SHAW & CO., INC.Reduced2.4MMay 15, 2026
JANUS HENDERSON GROUP PLCIncreased2.1MFeb 17, 2026
CITADEL ADVISORS LLCReduced2.1MMay 15, 2026
VIVO CAPITAL, LLCIncreased2.0MMay 20, 2026
BIOIMPACT CAPITAL LLCNew Position1.8MMay 15, 2026
LOGOS GLOBAL MANAGEMENT LPIncreased1.8MFeb 17, 2026
WEISS ASSET MANAGEMENT LPIncreased1.7MMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.